For: |
Kang KK, Lee DH, Oh DH, Yoon H, Shin CM, Park YS, Kim N, Jung HC. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i22/6932.htm |
Number | Citing Articles |
1 |
P Malfertheiner, F Megraud, C A O'Morain, J P Gisbert, E J Kuipers, A T Axon, F Bazzoli, A Gasbarrini, J Atherton, D Y Graham, R Hunt, P Moayyedi, T Rokkas, M Rugge, M Selgrad, S Suerbaum, K Sugano, E M El-Omar. Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report. Gut 2017; 66(1): 6 doi: 10.1136/gutjnl-2016-312288
|
2 |
Jae Kyu Sung. Diagnosis and Treatment of <i>Helicobacter Pylori</i> Infection. The Korean Journal of Medicine 2015; 89(2): 149 doi: 10.3904/kjm.2015.89.2.149
|
3 |
Jun Heo, Seong Woo Jeon, Jin Tae Jung, Joong Goo Kwon, Dong Wook Lee, Hyun Soo Kim, Chang Hun Yang, Jeong Bae Park, Kyung Sik Park, Kwang Bum Cho, Si Hyung Lee, Byung Ik Jang. Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial. Journal of Gastroenterology and Hepatology 2015; 30(9): 1361 doi: 10.1111/jgh.12983
|
4 |
Anthony O'Connor, Javier P. Gisbert, Colm O'Morain, Spiros Ladas. Treatment of Helicobacter pylori Infection 2015. Helicobacter 2015; 20(S1): 54 doi: 10.1111/hel.12258
|
5 |
Joon Sung Kim, Byung-Wook Kim, Su Jin Hong, Jin Il Kim, Ki-Nam Shim, Jie-Hyun Kim, Gwang Ho Baik, Sang Wook Kim, Hyun Joo Song, Ji Hyun Kim. Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. Gut and Liver 2016; 10(4): 556 doi: 10.5009/gnl15470
|
6 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 261 doi: 10.7704/kjhugr.2020.0045
|
7 |
Chang Min Lee, Seong Je Kim, Se In Hah, Ji Yoon Kwak, Jung Woo Choi, Hyun Chin Cho, Chang Yoon Ha, Ok Jae Lee, Woon Tae Jung. Comparison of eradication rates of moxifloxacin–rifabutin triple therapy and bismuth quadruple therapy as second‐line regimens in patients with peptic ulcers. Health Science Reports 2022; 5(5) doi: 10.1002/hsr2.780
|
8 |
Recep ALANLI, Murat Bulent KUCUKAY, Muhammet Fatih AYDIN, Bilal ERGÜL, Fahri YAKARYILMAZ. EFFICACY AND SAFETY OF GEMIFLOXACIN CONTAINING TREATMENT REGIMEN IN FIRST-LINE TREATMENT OF HELICOBACTER PYLORI. Arquivos de Gastroenterologia 2023; 60(3): 350 doi: 10.1590/s0004-2803.230302-23-51
|
9 |
Sumaira Khadim, Iyad Muhammad Naeem, Muhammad Tanveer Alam, Hina Rehman, Sidra Ghayas, Sajjad Haider. The efficacy of moxifloxacin-based triple-therapy in first-line treatment of Helicobacter pylori infection in Pakistan: randomized controlled trials. Archives of Medical Science – Civilization Diseases 2023; 8(1): 31 doi: 10.5114/amscd.2023.131926
|
10 |
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterología y Hepatología 2016; 39(10): 697 doi: 10.1016/j.gastrohep.2016.05.003
|
11 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. The Korean Journal of Internal Medicine 2021; 36(4): 807 doi: 10.3904/kjim.2020.701
|
12 |
Sung Min Park, Joon Sung Kim, Byung‐Wook Kim, Jeong‐Seon Ji, Hwang Choi. Randomized clinical trial comparing 10‐ or 14‐day sequential therapy and 10‐ or 14‐day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2017; 32(3): 589 doi: 10.1111/jgh.13510
|
13 |
Hideki Mori, Hidekazu Suzuki. Update on quinolone-containing rescue therapies for <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2020; 26(15): 1733-1744 doi: 10.3748/wjg.v26.i15.1733
|
14 |
Joon Sung Kim. The Optimal Second-line Rescue Therapy after Failure of Non-bismuth Quadruple Treatments. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(2): 145 doi: 10.7704/kjhugr.2015.15.2.145
|
15 |
Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi. The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure inHelicobacter pyloriEradication. The Korean Journal of Gastroenterology 2017; 70(2): 72 doi: 10.4166/kjg.2017.70.2.72
|
16 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of <i>Helicobacter pylori</i> Infection in Korea 2020. Gut and Liver 2021; 15(2): 168 doi: 10.5009/gnl20288
|
17 |
Alicia C. Marin, Olga P. Nyssen, Adrian G. McNicholl, Javier P. Gisbert. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis. Drugs 2017; 77(7): 765 doi: 10.1007/s40265-017-0730-4
|
18 |
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Spanish Consensus Conference on Helicobacter pylori infection treatment. Gastroenterología y Hepatología (English Edition) 2016; 39(10): 697 doi: 10.1016/j.gastre.2016.11.007
|
19 |
María Caldas, Ángeles Pérez-Aisa, Manuel Castro-Fernández, Luis Bujanda, Alfredo Lucendo, Luis Rodrigo, Jose Huguet, Jorge Pérez-Lasala, Javier Molina-Infante, Jesús Barrio, Luis Fernández-Salazar, Ángel Lanas, Mónica Perona, Manuel Domínguez-Cajal, Juan Ortuño, Blas Gómez-Rodríguez, Pedro Almela, Josep Botargués, Óscar Núñez, Inés Modolell, Judith Gómez, Rafael Ruiz-Zorrilla, Cristóbal De la Coba, Alain Huerta, Eduardo Iyo, Liliana Pozzati, Rosario Antón, Mercé Barenys, Teresa Angueira, Miguel Fernández-Bermejo, Ana Campillo, Javier Alcedo, Ramón Pajares-Villaroya, Marianela Mego, Fernando Bermejo, José Dominguez-Jiménez, Llúcia Titó, Nuria Fernández, Manuel Pabón-Carrasco, Ángel Cosme, Pilar Mata-Romero, Noelia Alcaide, Inés Ariño, Tommaso Di Maira, Ana Garre, Ignasi Puig, Olga Nyssen, Francis Megraud, Colm O’Morain, Javier Gisbert. European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain. Antibiotics 2020; 10(1): 13 doi: 10.3390/antibiotics10010013
|
20 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Medicine 2021; 96(3): 160 doi: 10.3904/kjm.2021.96.3.160
|